The Health-Tech Podcast #111: The Story of Unlearn.ai with Charles Fisher

Charles is a scientist with interests at the intersection of physics, machine learning, and computational biology and is the founder of Unlearn.ai . Previously, Charles worked as a machine learning engineer at Leap Motion and a computational biologist at Pfizer. He was a Philippe Meyer Fellow in theoretical physics at École Normale Supérieure in Paris, France, and a postdoctoral scientist in biophysics at Boston University. Charles holds a Ph.D. in biophysics from Harvard University and a B.S. in biophysics from the University of Michigan.


Unlearn creates Digital Twins to populate Intelligent Control Arms in clinical studies. While others leverage existing data, Unlearn generates a new type of data, for any type of patient. A Digital Twin is a longitudinal, computationally generated clinical record that describes what would have happened if a specific patient received a placebo.

https://www.linkedin.com/in/drckf/ | www.unlearn.ai

Get in touch:

www.jamessomauroo.com | www.somx.co.uk

Enter your email address to download paper.

Click the link to begin download.
Oops! Something went wrong while submitting the form.
Blog

Announcing The Unlearn Opportunities Internship Program

Podcasts

UCSF Rosenman Institute - The Health Technology Podcast #59: Digital Twins for Clinical Trials

Press

5 Q’s for Charles Fisher, CEO of Unlearn.AI

The Center for Data Innovation spoke with Charles Fisher, chief executive officer and founder of Unlearn.AI
Charles Fisher: Digital Twins for Clinical Trials
Creating Opportunities for Students of Data Science and Business from Underrepresented Groups in STEM